SCHEMBL6197010

SCHEMBL6197010

CCCCCCCCCCCCCCCCCCN1[CH]CCc2ccccc21

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.49
CYP2D6 P10635 3/20 0.49
CYP1A2 P05177 2/20 0.49
CYP2C19 P33261 1/20 0.49
MEN1 O00255 3/20 0.45
KMT2A Q03164 3/20 0.45
CHRM2 P08172 5/20 0.44
CHRM1 P11229 5/20 0.44
DRD2 P14416 5/20 0.44
CHRM3 P20309 5/20 0.44
DRD3 P35462 5/20 0.44
CHRM4 P08173 4/20 0.44
CHRM5 P08912 4/20 0.44
DRD4 P21917 4/20 0.44
SIGMAR1 Q99720 4/20 0.43
LMNA P02545 2/20 0.42
KDM4E B2RXH2 1/20 0.42
CES1 P23141 2/20 0.40
CDC25A P30304 1/20 0.40
ADRA1A P35348 3/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6197328 0.87 ALDH1A1 (0.50) ALDH1A1CYP2D6CYP1A2CYP2C19MEN1
SCHEMBL1100574 0.82 ALDH1A1 (0.49) ALDH1A1CYP2D6CYP1A2CYP2C19MEN1
SCHEMBL2157866 0.80 ALDH1A1 (0.41) ALDH1A1CYP2D6CYP1A2MEN1KMT2A
SCHEMBL12307218 0.77 HTR2A (0.64) ALDH1A1CYP2D6CYP1A2CYP2C19MEN1
SCHEMBL7835662 0.77 DRD2 (0.44) ALDH1A1CYP2D6CYP1A2CYP2C19MEN1
SCHEMBL12307238 0.77 HTR2A (0.64) ALDH1A1CYP2D6CYP1A2CYP2C19MEN1
SCHEMBL12307233 0.77 HTR2A (0.64) ALDH1A1CYP2D6CYP1A2CYP2C19MEN1
SCHEMBL1450281 0.77 ALDH1A1 (0.43) ALDH1A1CYP2D6CYP1A2MEN1KMT2A
SCHEMBL1450327 0.76 LMNA (0.58) ALDH1A1CYP2D6CYP1A2MEN1KMT2A
SCHEMBL9158087 0.75 ALDH1A1 (0.49) ALDH1A1CYP2D6CYP1A2CYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1130017-B1 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMA CO LTD (JP) 2005-06-15 EP disclosed
EP-0934937-B1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMA CO LTD (JP) 2002-02-27 EP disclosed
US-RE37556-E1 (ALKOXYPHENYL)THIAZOLE DERIVATIVES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2002-02-19 US disclosed
EP-1130017-A2 Azole derivatives and their use as superoxide radical inhibitors OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2001-09-05 EP disclosed
US-6080764-A PROTECTING VARIOUS TISSUE CELLS FROM DISTURBANCES ASSOCIATED WITH ISCHEMIA AND BLOOD REPERFUSION IN HEART, BRAIN, KIDNEY, LUNG AND DIGESTIVE TRACT BY INHIBITING SUPEROXIDE-RELEASE BY NEUTROPHILIC LEUKOCYTES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 2000-06-27 US disclosed
EP-0934937-A1 Azole derivatives as superoxide radical inhibitor OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1999-08-11 EP disclosed
US-5677319-A THIAZOLE DERIVATIVE OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-10-14 US disclosed
US-5643932-A PREVENTS CELL DAMAGE AFTER ISCHEMIA AND RE-PERFUSION, SUBSTITUTED THIAZOLES OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1997-07-01 US disclosed
EP-0513387-A1 ACTIVE OXYGEN INHIBITOR OTSUKA PHARMACEUTICAL CO., LTD. (JP) 1992-11-19 EP disclosed